Latest News and Press Releases

UPPSALA, Sweden, May 12, 2003 (PRIMEZONE) -- Q-Med: Sales increased by 24 percent to SEK 141.3 (113.7) million. Adjusted for changes in exchange rates, sales increased by 33 percent. On a rolling...

UPPSALA, Sweden, March 10, 2003 (PRIMEZONE) -- The American antitrust authority, Federal Trade Commission earlier approved Medicis (NYSE:MRX) acquisition of HA North American Sales AB from Q-Med...

UPPSALA, Sweden, March 5, 2003 (PRIMEZONE) -- The American antitrust authority, Federal Trade Commission, approves Medicis (NYSE:MRX) acquisition of HA North American Sales AB from Q-Med...

UPPSALA, Sweden, Feb. 10, 2003 (PRIMEZONE) -- Q-Med (Stockholm:QMED): -- Sales increased during the year by 36 percent to SEK 517.8 (380.2) million. During the fourth quarter turnover...

UPPSALA, Sweden, Feb. 10, 2003 (PRIMEZONE) -- The Q-Med Group (Stockholm:QMED) has signed an agreement to divest all shares in the wholly-owned subsidiary HA North American Sales AB to Medicis...

UPPSALA, Sweden, Nov. 15, 2002 (PRIMEZONE) -- Erika Kjellberg Eriksson, who was appointed acting Chief Financial Officer at Q-Med (Stockholm:QMED) on September 24, has been appointed permanent Chief...

UPPSALA, Sweden, Sept. 24, 2002 (PRIMEZONE) -- Erika Kjellberg Eriksson has been appointed acting Chief Financial Officer at Q-Med (Stockholm:QMED) and thereby replaces the former Chief Financial...

UPPSALA, Sweden, Aug. 22, 2002 (PRIMEZONE) -- Q-Med: -Continued strong growth. Sales increased by 46 percent to SEK 253.4 (174.0) million. On a rolling 12-month basis sales rose by 51 percent to...

UPPSALA, Sweden, June 19, 2002 (PRIMEZONE) -- The application for registration in order to obtain marketing approval in the U.S.A. has been submitted according to plan to the FDA (Food and Drug...

UPPSALA, Sweden, May 6, 2002 (PRIMEZONE) -- In the clinical study in the USA where the Swedish company Q-Med's* product RESTYLANE has been compared with a competing collagen-based product, the effect...